<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huybrechts Y</submitter><funding>Research Foundation - Flanders</funding><funding>Methusalem - OEC grant - &amp;quot;GENOMED&amp;quot;</funding><pagination>80</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8774882</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>Sclerosteosis is a high bone mass disorder, caused by pathogenic variants in the genes encoding sclerostin or LRP4. Both proteins form a complex that strongly inhibits canonical WNT signaling activity, a pathway of major importance in bone formation. So far, all reported disease-causing variants are located in the third β-propeller domain of LRP4, which is essential for the interaction with sclerostin. Here, we report the identification of two compound heterozygous variants, a known p.Arg1170Gln and a novel p.Arg632His variant, in a patient with a sclerosteosis phenotype. Interestingly, the novel variant is located in the first β-propeller domain, which is known to be indispensable for the interaction with agrin. However, using luciferase reporter assays, we demonstrated that both the p.Ar</pubmed_abstract><journal>Genes</journal><pubmed_title>Identification of Compound Heterozygous Variants in LRP4 Demonstrates That a Pathogenic Variant outside the Third β-Propeller Domain Can Cause Sclerosteosis.</pubmed_title><pmcid>PMC8774882</pmcid><funding_grant_id>12A3814N</funding_grant_id><funding_grant_id>G031915N</funding_grant_id><funding_grant_id>FFB190208</funding_grant_id><pubmed_authors>Bracamonte MS</pubmed_authors><pubmed_authors>Hamdy N</pubmed_authors><pubmed_authors>Steenackers E</pubmed_authors><pubmed_authors>Huybrechts Y</pubmed_authors><pubmed_authors>Martinez Diaz-Guerra G</pubmed_authors><pubmed_authors>Appelman-Dijkstra NM</pubmed_authors><pubmed_authors>Boudin E</pubmed_authors><pubmed_authors>Hendrickx G</pubmed_authors><pubmed_authors>Van Hul W</pubmed_authors><pubmed_authors>Mortier G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of Compound Heterozygous Variants in LRP4 Demonstrates That a Pathogenic Variant outside the Third β-Propeller Domain Can Cause Sclerosteosis.</name><description>Sclerosteosis is a high bone mass disorder, caused by pathogenic variants in the genes encoding sclerostin or LRP4. Both proteins form a complex that strongly inhibits canonical WNT signaling activity, a pathway of major importance in bone formation. So far, all reported disease-causing variants are located in the third β-propeller domain of LRP4, which is essential for the interaction with sclerostin. Here, we report the identification of two compound heterozygous variants, a known p.Arg1170Gln and a novel p.Arg632His variant, in a patient with a sclerosteosis phenotype. Interestingly, the novel variant is located in the first β-propeller domain, which is known to be indispensable for the interaction with agrin. However, using luciferase reporter assays, we demonstrated that both the p.Ar</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-04T13:48:17.914Z</modification><creation>2022-02-11T15:52:18.726Z</creation></dates><accession>S-EPMC8774882</accession><cross_references><pubmed>35052419</pubmed><doi>10.3390/genes13010080</doi></cross_references></HashMap>